Results 271 to 280 of about 88,244 (379)

Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles

Acta Pharmacologica Sinica, 2017
Feng Chen, H. Valdovinos, R. Hernandez, Shreya Goel, T. Barnhart, W. Cai   +5 more
semanticscholar   +1 more source

Heterotrophic diazotrophy along a river–lake continuum: Lifestyle and contribution to dinitrogen fixation

Limnology and Oceanography, Volume 71, Issue 1, January 2026.
Abstract Heterotrophic diazotrophs are potentially important to the nitrogen cycle in freshwater ecosystems, yet their abundance, N2 fixation rates, diversity, and association with aggregates remain poorly understood. This study elucidates the contribution of freshwater heterotrophic diazotrophs as free‐living or aggregate‐associated cells to total N2 ...
Eyal Geisler, Hagar Siebner, Max Kolton, Guy Sisma‐Ventura, Eyal Rahav, Shai Arnon, Edo Bar‐Zeev   +6 more
wiley   +1 more source

Clinical evaluation of novel blood collection and storage bags containing alternative plasticizers to DEHP: Recommendations from the BEST collaborative. [PDF]

Transfusion
Brown B, Klei TRL, Kanias T, de Korte D, Cancelas JA, Cardigan R, Biomedical Excellence for Safer Transfusion (BEST) Collaborative.   +6 more
europepmc   +1 more source

Optimization of radiolabeled PEG-liposomes for scintigraphic applications

, 2000
Peter Laverman
openalex   +1 more source

Mass spectrometry in ocular drug research

Mass Spectrometry Reviews, Volume 45, Issue 1, Page 37-68, January/February 2026.
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo, Kati‐Sisko Vellonen, Arto Urtti, Tetsuya Terasaki, Anam Hammid, Paavo Honkakoski, Seppo Auriola   +6 more
wiley   +1 more source

Radiolabeling isolated mitochondria with Tc-99m: A first-in-field protocol and early feasibility findings. [PDF]

Biol Methods Protoc
Walker M, Miralles FJ, Prijoles K, Kazmi JS, Hough J, Lewis D, Levitt MR, Sancak Y.   +7 more
europepmc   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

Medicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller, Nadia Bom Pedersen, Vladimir Shalgunov, Andreas Ingemann Jensen, Umberto Maria Battisti, Matthias Manfred Herth   +5 more
wiley   +1 more source

⁶⁸Ga-radiolabeled fluorescent dye for potential non-invasive multimodal imaging of subarachnoid hemorrhage. [PDF]

EJNMMI Radiopharm Chem
Gerhards JW, Schäfer L, Kang D, Lindauer U, Lütje S, Mottaghy FM, Schmidt T, Vogg ATJ.   +7 more
europepmc   +1 more source

Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy.

ACS Nano, 2015
Teng Liu, Sixiang Shi, Chao Liang, Sida Shen, Liang Cheng, Chao Wang, Xuejiao Song, Shreya Goel, T. Barnhart, W. Cai, Zhuang Liu   +10 more
semanticscholar   +1 more source

Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [¹⁸F]ENL30: A Potential PET Radiotracer for the 5-HT₇ Receptor

, 2019
Elina Tampio L’Estrade, Fraser Edgar, Mengfei Xiong, Vladimir Shalgunov, Simone Larsen Bærentzen, Maria Erlandsson, Tomas Ohlsson, Mikael Palner, Gitte M. Knudsen, Matthias M. Herth   +9 more
openalex   +1 more source